Key result
The Sokolow-Lyon index demonstrated poor diagnostic performance for detecting left ventricular hypertrophy with an AUC of 55.3% and sensitivity of 5%, despite a weak association with left-ventricular mass index.
Why the study?
Does the Sokolow-Lyon index accurately detect echocardiographically diagnosed left ventricular hypertrophy in a general population?
Cross-Sectional (n=1,779)
No
Does the Sokolow-Lyon index accurately detect echocardiographically diagnosed left ventricular hypertrophy in a general population?
Mean Difference: 7 (95% CI 4.5–9.5)
p-value: p=<0.0001
The Sokolow-Lyon index has poor sensitivity and weak overall diagnostic performance for detecting echocardiographic left ventricular hypertrophy, suggesting it is not an effective screening tool in the general population.
SLI's poor sensitivity precludes routine LVH screening in general populations; leaves open need for refined ECG criteria or imaging validation in cohorts.
BACKGROUND: Arterial hypertension is a common disease with high prevalence in the general population. Left ventricular hypertrophy (LVH) is an independent risk factor in arterial hypertension. Electrocardiographic indices like the Sokolow-Lyon index (SLI) are recommended as diagnostic screening methods for LVH. We assessed the diagnostic performance of the SLI in a cohort of a large general population. METHODS: We used electrocardiographic and echocardiographic data from the prospective, population-based cohort study CARdio-vascular Disease, Living and Ageing in Halle (CARLA). Linear and logistic regression models were used to assess the association of SLI with LVH. To assess the impact of the body-mass-index (BMI), we performed interaction analyses. RESULTS: AUC of SLI to predict LVH was 55.3 %, sensitivity of the SLI was 5 %, specificity 97 %. We found a significant association of SLI after covariate-adjustment with echocardiographically detected LVH (increase of left-ventricular mass index, LVMI 7.0 g/m(2) per 1 mV increase of SLI, p < 0.0001). However, this association was mainly caused by an association of SLI with the left-ventricular internal diameter (LVIDd, increase of 0.06 cm/m(2) per 1 mV increase of SLI, p < 0.0001). In obese (BMI > 30 kg/m(2)) we found the strongest association with an increase of 9.2 g/m(2) per 1 mV. CONCLUSIONS: Although statistically significant, relations of SLI and echocardiographic parameters of LVH were weak and mainly driven by the increase in LVIDd, implicating a more eccentric type of LVH in the collective. The relations were strongest when obese subjects were taken into account. Our data do not favour the SLI as a diagnostic screening test to identify patients at risk for LVH, especially in non-obese subjects without eccentric LVH.
No takes yet. Share an insight, caveat, or question.
Schröder et al. (2015) conducted a cross-sectional in Left ventricular hypertrophy (n=1,779). Sokolow-Lyon index was evaluated on Increase in left-ventricular mass index (LVMI) per 1 mV increase in Sokolow-Lyon index (MD 7.0, 95% CI 4.5-9.5, p=<0.0001). The Sokolow-Lyon index demonstrated poor diagnostic performance for detecting left ventricular hypertrophy with an AUC of 55.3% and sensitivity of 5%, despite a weak association with left-ventricular mass index.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: